In the treatment of aggressive lymphomas and blood cancer (leukemia), so-called chimeric antigen receptor T cells (CAR T cells) are increasingly being used. For this therapy, immune cells are taken ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback